Concepedia

Tadeusz Kubicki

TK

8

Publications

311

Citations

8

H-Index

2016

Active since

Affiliations

Poznan University of Medical Sciences(Current)

Wroclaw Medical University

Medical University of Lublin

University of Chicago

Instytut Hematologii i Transfuzjologi

Tadeusz Kubicki is an author at Poznan University of Medical Sciences specializing in oncology, hematology, and medicine.

ORCID

Top concepts

Publications per year

2016–2024

8

Publications

8

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma

Jagoda Jasielec, Tadeusz Kubicki, Noopur Raje et al. · Blood · 2020 · 72 citations · Full text

Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial

Dominik Dytfeld, Tomasz Wróbel, Krzysztof Jamroziak et al. · The Lancet Oncology · 2023 · 69 citations · Full text

, , +10

Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy

Dominik Dytfeld, Magdalena Łuczak, Tomasz Wróbel et al. · Oncotarget · 2016 · 68 citations · Full text

Mass spectrometry–based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma

Tadeusz Kubicki, Dominik Dytfeld, David R. Barnidge et al. · Blood · 2024 · 27 citations · Full text

Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP)

Benjamin A. Derman, Ajay Major, Jennifer H. Cooperrider et al. · Blood Cancer Journal · 2024 · 25 citations · Full text

Rows per page

1–5 of 8